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ABS 1 UA( I
Neisseria Meningitidis is a pathogenic bacteria responsible for a wide range of serious 
disease, including septsis and meningitis especially in children and infants. In contrast 
Neisseria Laetamica which resides in the same ecological niche as N.meningitidis, the 
nasopharynx, does not cause disease and is commensal It was found that the two species of 
Neisseria have converse carriage rates where N.laetamica has a protective role over 
N.meningitidis colonization in infants. The two species have similar structural components 
and genes but very different pathogenesis. It is clear that N.meningitidis adheres and 
invades host cells whereas N.laetamica does not invade.
Adhesion of N.laetamica  seems to occur mostly around the side* of  t h e  cell rather than the 
apex or base. Adhesion numbers of N.laetamica increase with time of infection with a 
greater increase from 4 I * *  <■ hours rather than 2 to 4 hours of infection. Adhesion rates in 
relation to A.meningitidis adhesion numbers were less which may be due to greater 
adhesive ability of N.meningitidis. Inhibitor treatment of epithelial cells and thus, a 
decrease in cellular inflammatory response, resulted in a greater degree o f adhesion and 
again from 4 to 6 hours, the increase in adhesion numbers were greater than from. 2 to 4 
hours. Supernatant quantifications showed an increase in N.laetamica  with time,which may 
reflect growth of bacteria during the course o f infection.
Further experimentations with advanced techniques such as eonfocai microscopy and more 
repeats of the gentamycin assay would yield more promising results. Also, the analysis of 
supernatant for inflammatory mediators, bactericidal compounds, and bacterial by products 
is necessary in order to determine the dynamics of adhesion o f  N. laetamica.
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A B B R E V I A T I O N S
« 11 Colons 1 <‘nning Units
t>\PI 4,-6-Diamidino-2-pheriylindole
DMEM Dulbecco’s modified eagle medium
F€S Fetal Calf Serum
FITC Fluorescein Isothiocyanate
! \ t  ; In te rfero n - gam m a
11 1f Interleukin t fmta
IL-1 Interleukin-1
IL-2 Interleukin-2
IL-3 Interleukin--3
11-12 Interleukin I v
LPS Lipopolysacchande
LOS L ipoo 11 go s ac ch an de
MAPK Mitogen-Activated Protein Kinase
MEK MAPK-activating enzymes
MH Mueller-Hinton
MOI Multiplicity of Infection
N.gonorrhoeae Ne isseria Gonorrhoeae
N.laetamica Neisseria Laetamica 
N. meingilidis Neisseria Meningitidis
NOD Nucleotide Oligomerisation Domain
OD Optical. Density
OMP Outer Membrane Proteins
OMV Outer Membrane Vesicles
PBS Phosphate Buffered Saline
RON Reactive Oxygen Species
Rho/Phal Rhodamine/Phalloidin
RPMI Roswell. Park Memorial Institute
TLR Toll-I ike Receptors
TNFa Tumour Necrosis Factor-alpha
CHAPTER I
I M U O I X  ( MON
The appliance of microbiology in the prevention, diagnosis, and cure of disease has 
revolutionised human health. The average life span of human beings has doubled and the 
survival rates of children are much greater. The battle against global epidemics, such as 
smallpox that had cost so many lives seem to be more or less conquered and at present day 
in the developed world more focus is on mental illnesses and degenerative disease. 
Mortality due to tuberculosis, which is miniscule in the Western world, reaches 3 million a 
year in the less-developed world m M>‘enwood, Slack, & Petherer 2002).
In order to free societies from fatal infections continuous and strict countermeasures must 
be set (Greenwood, Slack, & Petherer 2002). These are. 
continuous epidemiological surveillance 
hygiene and control of infection 
carry out immunization programmes 
accurate diagnosis and treatment
It is possible that, due to the difficulty in following the above measures in less-developed 
countries, there is a much larger threat towards human life. One example of an infections 
bacteria that has killed so many throughout history is Yersinia perils also known as plague.
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It was responsible for the killing of nearly a third of Europe’s population in the middle ages 
(www.themtddleages.net 2006). Nowadays, immunization and sanitation has eliminated 
plague in the Western world but in less-developed countn.es, such as the it still exists as 
endemics (WHO 2004).
These epidemiological data are evidences of the significance o f bacterial infections and 
thus, there is still a great need for studies into pathogenic bacteria. In order to understand 
and develop potential treatments or vaccines against harmful pathogenic bacteria, the 
epidemiology, structure, genomics, and pathogenesis must be understood.
One very good example of two species of the same family that occupy a common niche 
within the human host are Neisseria Meningitidis (N.meingitidis) and Neisseria Laetamica 
(N.laetamica). These two species are closely related and they both colonise the 
nasopharynx o f humans but with opposite consequences. N. meningitidis is well known to 
cause a range of serious disease whereas N .laetamica very rarely causes disease and is part 
of the natural bacterial flora o f the nasopharynx (Collee et al. 1996;Greenwood, Slack, & 
Petherer 2002),
Now, for the purpose of this project, the epidemiology, structure, genomics, pathogenesis, 
and key similarities and differences will be discussed regarding these two species of the 
Neisseria family, N.meningitidis and N.laetamica.
L I . Neisseria Meningitidis
N.meningitidis belong to the genus Neisseria, which include other members such as the 
pathogen, N.gonorrhoeae and the non-palhogenic commensal N.laetamica. They are gram- 
negative diplococci and humans are the only natural carriers, found predominantly in the 
nasopharynx (Collee et al. 1996;Murray, Rosenthal, & Pfaller 2005). Their capsular
polysaccharide antigens define the serogroups to which each member belongs to. The 
serogroups are A, B < , \ ,  Y. /  N'-Iy and \\ 1 A **t which groups, A, B, and €  are 
associated with epidemics (Dupuy et al. 2006). It causes a wide range of disease depending 
on the site of infection but almost a third of cases present as fatal septicaemia with the 
remaining two thirds as meningitis (Collee et al. 1996;Greenwood, Slack, & Petherer 20**f i
1.1.1. Epidemiology
N.meningitidis is a pathogen of global significance and remains as one o f the most feared 
infections. Its rapid progression and tendency to cause widespread epidemics are the cause 
of a high mortality rate of 20-50% (Morley & Pollard 2002;Rosenstein et al. 1999). 
Although other serious infectious disease are prevented with successful vaccination 
programs in temperate countries, meningococcal disease remains as the most frequent cause 
of death in childhood due to infections (Morley & Pollard 2002).
Clinical meningococcal disease was first described in 1805 during an outbreak in the 
vicinity o f Geneva, Switzerland by Vieusseux (Evens & Brachman 1998). The major 
outbreaks during the 20th century were during the two World Wars possible due to crowded 
and enclosed conditions during large scale mobilization. But meningococcal meningitis has 
occurred throughout the world sporadically in small clusters (Fig. 1.1) (Dupuy et al. 
2006;WHO 2006). Regardless o f the climate o f the country, meningococcal epidemics can 
occur anywhere especially dry seasons.
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Fig.1.1. Ma jor epidemics of meningococcal meningitis from 1971 to 1997 
(Dupuy et al. 2006)
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But by far the highest burden of meningococcal disease occurs in sub-Saharan Africa, 
distinctively in the region called the ‘Meningitis belt’ (Fig. 1.2 ). This hyperendemic area is 
home to attack rates o f 100-800 per 100,000 population during major African epidemics in 
which serogroups, A, C, and W135 are the main players o f meningococcal disease. High 
susceptibility in this area is due to the climate during the dry season where respiratory tract 
infections are common due to dust winds and cold nights. Also the transmission of 
N meningitidis is escalated by overcrowded housing and large scale mobilizations during 
pilgrimages (Dupuy et al. 2006;WHO 2006).
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Fig.1.2. The African meningitis belt. Extending from Ethiopia in the East, to Senegal
in the West. (Dupuy et al. 2006)
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Epidemiological data reveals certain behavior or geographical location that increases 
susceptibility to infection. It is indeed true that ‘overcrowding’ sharply increased carrier 
rate o f N. meningitidis. Especially during World War I and the massive epidemic in Chille 
during 1941-1942, population density was very high leading to amplified carriage rates 
(Evens & Brachman 1998). Temporal factors also play a role in sporadic endemic cases 
where most cases are seen during diy seasons in Africa and in the USA, incidence peaks in 
late winter and early spring. This may be due to a change in sleep patterns in more crowded 
rooms (Evens & Brachman 1998;Rosenstein et al. 1999). Another key factor in 
meningococcal disease is age. Meningitis is a childhood disease and most often seen in 
children below the age o f 15. Age specific incidence is highest among infants between 3 
and 12 months in temperate countries and mortality reached 80-90% in children in some 
epidemics before effective therapeutics (Evens & Brachman 1998). Incidence o f 
meningococcal infections during 1984 and 1991 in England and Wales was maximum at 6 
months o f age and declined towards the age o f 4. Although certain strains were found to be 
associated with disease in older children and young adults (Jones & Mallard 1993).
15
1.1.2. Clinical manifestation
Spread of N.meningitidis usually occurs by droplet exposure which results in asymptomatic 
carriage most o f the time. The progression from carriage to invasive disease results in 
septicaemia and/or meningitis with fever and a characteristic feature is a non-blanching 
purpuric rash. The severity varies greatly amongst individuals from bacteraemia to severe 
septicaemia and invasive disease rarely can take the form o f  arthritis or pneumonia (Morley 
& Pollard 2002).
Children are at greatest risk from disease although many studies have indicated protection 
against N.meningitis in infants under the age o f 6 months. Risk factors include, 
active/passive smoking (Ahmer et al. 1999), overcrowding, poverty, young age, exposure to 
respiratory infections, and complement deficiency.
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1.1.3. Structure and Classification
N meningitidis are bean-shaped gram-negative diplococci with either flat or concave 
opposing edges (Fig. 1.3.). They are 0.8pm in diameter and have an outer membrane, a layer 
of peptidoglycan in the periplasmic space, and an inner membrane that contains cytoplasm 
and DNA (Fig.l .4.) (Brooks, Butel, & Morse 2004;Collee et al. 1996).
Fig.l .3. Scanning Electron Microscope image of N. meningitidis. 
(taken from www.waterscan.co.yu)
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Fig.l.4. N.meningitidis membrane structures. Outer and inner membrane structures 
and peptidoglycan structures shown together with various outer membrane proteins, 
(PorA, PorB, Opa), Lipopolysaccharide (LPS), and Pilus. (Morley & Pollard 2002)
As shown by Fig.l .4., the outer membrane is surrounded by a polysaccharide capsule 
which protects N.meningitidis against phagocytosis, complement-mediated lysis and other 
environmental abuse but do not induce an inflammatory response in the host (Brandtzaeg & 
van Deuren 2005;Morley & Pollard 2002). Due to these protective properties, it is clear that 
only pathogenic meningococci contain a polysaccharide capsule (Manchanda, Gupta, & 
Bhalla 2006). According to the antigenic and chemical properties of specific polysaccharide
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capsules, N.meningitidis can be classified into 12 distinct serogroups (A, B, C, H, I, K, L, 
M, X, Y, Z, 29E, and W135), o f which meningitidis from the 5 serogroups (A, B, C, Y and 
W135) are most infectious and thus responsible for most world-wide epidemics (Evens & 
Brachman 1998;Greenwood, Slack, & Petherer 2002;Manchanda, Gupta, & Bhalla 2006). 
Typically, serogroup A strains are associated with large scale epidemics whereas serogroup 
B strains occur in hyperendemic or sporadic cases (Tettelin et al. 2000).
Lipopoly saccharides (LPS) are the major components on the surface o f the outer membrane 
(Fig. 1.4.). In meningococci, LPS is also called lipooligosaccharide (LOS) due to its shorter 
length. This endotoxin structure confers serum resistance and involved in pathogenesis of  
meningococcal disease (Morley & Pollard 2002;Vogel & Frosch 1999). They induce strong 
proinflammatory immune responses in the host and are thought to hide away from the 
immune system by undergoing phase variation in order to pass through the mucosal barrier 
(Brandtzaeg & van Deuren 2005;Plant et al. 2006).
Another group o f structures found on the outer membrane are outer membrane proteins 
(OMP) embedded within the lipid bilayer. As shown by Fig. 1.4., PorA and PorB proteins 
are porins that allow ion transportation across the impermeable lipid bilayer. These proteins 
are major epitopes recognized by the immune system and are also highly variable 
(Brandtzaeg & van Deuren 2005). Depending on the antigenic differences o f these OMPs, 
N.meningitidis can be further classified into serotypes and subtypes based on the PorB and
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PorA proteins respectively (Morley & Pollard 2002). Other protein structures include Opa 
and Opc opacity proteins which contributes to cell adhesion and invasion.
Thus, N.meningitidis are currently classified as [serogroup]:[serotype]:[subtype]:[LOS 
immunotype] according to the characteristics o f the surface antigens. Classification is 
useful in epidemiologic studies as some serotypes are associated with epidemics 
(Greenwood, Slack, & Petherer 2002) and it is also important for vaccine development 
(Manchanda, Gupta, & Bhalla 2006).
Finally, a long filamentous structure consisting o f several subunits are found on the outer 
surface. This structure is called pili and N.meningitidis produce a type IV pili which 
attaches to CD46, expressed on most human cells. Pili are important for pathogenic 
Neisseria species to exert virulence and are encoded by expression o f the pilE  locus (Aho, 
Keating, & McGillivray 2000). They are also required for obtaining bacterial DNA required 
for displaying genetic diversity (Brandtzaeg & van Deuren 2005).
1.1.4. Genomics
Elucidation of the genomics o f N. meningitidis is important in order to reveal mechanisms 
o f interaction with the host. Still our understanding o f meningococcal invasion and 
infection is incomplete but with new genomic technologies, soon complete genome
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sequences for all pathogenic N.meningitidis strains will help to uncover disease-causing 
mechanisms (Feavers 2000;Grifantini et al. 2002).
Currently, the genomes o f two strains o f N. meningitidis have been sequenced. Complete 
genome sequences o f N. meningitidis serogroup A strain Z2491 (Parkhill et al. 2000) and 
serogroup B strain MC58 are now available (Tettelin et al. 2000). Both these sequences are 
around 2.2MB in length and have a GC content o f about 52%.
The prominent feature o f these genome sequences was the presence o f highly repetitive 
elements from short (10-200 bp) to large sequences (Nassif 2002). These elements are 
involved in antigenic variation and especially important for the natural transformability and 
fluidity o f the genome o f N. meningitidis (Nassif 2002;Parkhill et al. 2000). A large 
proportion o f these sequences were associated with genes encoding outer membrane 
proteins involved in interaction with host cells (Feavers 2000). These include genes for the 
type IV pilus, Opa proteins and Opc proteins. Especially, antigenic variation o f the pilus 
proteins is important in evasion o f host clearance mechanisms (Tettelin et al. 2000). The 
mechanism is shown in Fig. 1.5. where the variable region o f the pilE  expression locus 
receives a transfer o f DNA from numerous silent pilS  loci via RecA-mediated 
recombination (Davidsen & Tonjum 2006). Additionally, previous identified genes 
encoding the capsular polysaccharide and LPS were also present(Klein et al. 1996).
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Phase variation controls gene expression and most genes responsible for host interactions 
are found to be phase-variable. These genes were found at a much greater number than in 
other organisms (Tettelin et al. 2000).
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Silent p IS  loci 
]— [ pi1S5 piiSl
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\ \ — i [""-i pii 54
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Fig.l JS. Antigenic variation ofpilE  expression locus.
Gene conversion occurs by DNA transfer from pilS loci to the variable pilE locus via RecA. 
(Davidsen & Tonjum 2006)
Additionally, due to absent DNA-repair genes such as those found in Esherichia coli,
N.meningitidis produces an excess of spontaneous genetic variants. This again is 
advantageous in its interaction with the host bring about antigenic changes relevant to 
adherence and invasion (Davidsen & Tonjum 2006).
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Fig.l.6. Horizontal gene transfer involving type IV pili, and various Pil proteins.
The exogenous DNA is intergrated into the meningitidis genome by homologus 
recombination. (Davidsen & Tonjum 2006)
Also, transformations that contribute to horizontal gene transfer are another way to increase 
antigenic variance. As shown by Fig. 1.6., exogenous DNA is caught by the retracting type 
IV pili and taken up and intergrated into the N.meningitidis genome by various Pil proteins. 
Reassuringly, 3 major regions with unusual nucleotide composition obtained by horizontal 
transfer were also present in the full genome sequence o f strain, MC58 (Tettelin et al. 2000), 
The wide availability of the genome sequences o f Nmeningitidis strains will definitely 
accelerate development of vaccines providing protection against pathogenic meningococci.
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1.1.5. Host Defense
The respiratory system has two major mechanisms to protect against potential disease- 
causing pathogens. The first is the mucociliary clearance, where a combination o f ciliary 
motion, secretion o f mucins and other macromolecules and fluid facilitates the clearance of  
inhaled particles towards the mouth where it is swallowed (Farmer & Hay 1995). The 
second mechanism is mucous secretion. Mucus entraps inhaled particles and prevents direct 
contact with epithelial cells and the mucous gel becomes thicker in inflammatory 
conditions. In addition, epithelial cells secrete a large variety o f macromolecules with 
bactericidal functions (Farmer & Hay 1995).
The epithelium plays a key role in host defense against microbes. Recognition systems such 
as the Toll-like receptors (TLRs), Nucleotide oligomerisation domain (NOD) receptors are 
present to activate antibacterial effector mechanisms on demand (Bajaj-Elliott 2005). The 
overall response is that the epithelium increases production o f cytokines, chemokines and 
antimicrobial peptides which mediate effector molecules for killing microbes but also as 
regulators of cellular inflammation and immunity (Bals & Hiemstra 2004).
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1.1.6. Pathogenesis
N.meningitidis is a known pathogen o f  significance but in actual fact, many N. meningitidis 
do not produce disease and reside in the nasophaiynx and the host presents as a carrier.
The reason behind the small percentage o f invasive meningococcal disease is unknown but 
predisposing factors such as inhalation o f diy dusty air or passive smoking increase the risk 
oiN.meningitidis invasion (Pathan, Faust, & Levin 2003).
In order for N.meningitidis to produce the systemic infections, it must rise above specific 
and non-specific mucosal defences, it must be able to cross the upper respiratory 
mucociliary sheath, and also needs to attach to epithelial cells. All these features must be 
overcome in order to successfully colonize the nasophamynx (Tzeng & Stephans 2000). 
Thus, N.meningitidis has evolved genetic mechanisms to survive as a commensal and at 
times an invader into the bloodstream. Two prominent mechanisms are ‘antigenic variation’ 
of components o f the outer membrane and ‘horizontal DNA exchange’ through 
transformations as explained above (Tzeng & Stephans 2000).
Additionally, structures on its outer membrane are crucial for its survival in the host. Its 
polysaccharide capsule promotes adherence and inhibits opsonophagocytosis and the 
production o f various factors inhibit ciliary clearance activity (Pathan, Faust, & Levin 
2003)
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Major structures that give N.meningitidis its virulence are the structures found on the outer 
surface o f the bacteria. These are the pili, lipooligosaccharides (LOS), capsular 
polysaccharide, and outer membrane proteins (OMPs) (Tzeng & Stephans 2000).
Meningitis and its clinical outcome are due to activation o f inflammatory cytokines, 
leukocyte infiltration across the blood brain barrier, breakdown o f blood brain barrier due 
to oedema, induction o f cellular apoptosis, coagulation o f vessels and ischaemia.
In reality, more damage is done to host tissues by the immune system. As shown in Fig. 1.7., 
the meningococcal endotoxin is the prime factor that triggers the host immune system. 
Endotoxin is released via ‘blebbing’ o f the outer membrane and large amounts are 
delivered in pockets o f vesicles into the bloodstream (Fig. 1.8.). CD14 is the prime receptor 
that binds endotoxin which in turn activates macrophages to produce proinflammatoiy 
cytokines (TNFa and IL-113). It can also activate the 3 different types o f complement 
pathway (classical, alternative, or mannose-binding lectin pathway), which in turn can 
activate neutrophils to excessively release reactive oxygen species (ROS) resulting in 
endothelial cell damage (Hackett, Thomsom, & Hart 2001 pathan, Faust, & Levin 2003).
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Fig. 1.7. Inflammatory cascade in meningococcal septicaemia.
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Fig. 1.8. Membrane blebbing in Meningococci. (Hackett, Thomsom, & Hart 2001)
It may seem that cytokines are at the centre o f disease progression and it is true that 
cytokine levels correlate with disease severity. But the complement system is essential for 
protection o f the host to future encounter with N.meningitidis. Individuals with deficiencies 
to the terminal steps o f the complement pathway suffer recurrent infections (Mathew & 
Overturf 2006).
Infection o f N.meningitidis occurs through 3 major steps. The first step is the attachment to 
host cells via surface-associated filaments celled type IV pili and Opa protein adhesins. 
They attach in microcolonies typically o f about 10-100 diplococci and is accompanied by 
elongation of host cell microvilli (Fig. 1.9. A). The host cell receptors for this type IV pili 
was identified as CD46 which is present in several types o f human cells (epithelial, 
endotheial and sperm cells) (Kallstrom et al. 1997;Merz & So 2000). The binding of CD46 
was shown to result in decreased interleukin-12 (IL-12) expression leading to decreased 
immunity (Karp et al. 1996), which N. meningitidis takes advantage o f during attachment. 
During the next stage, bacteria is dispersed from the microcolonies and become closely 
associated with the host plasma membrane, enlarging its contact surface area with the host 
cell (Fig.l.9.B and C). And finally Neisseria is internalized by engulfment by the epithelial 
cells (Merz & So 2000). The invasion process again involves various surface proteins such 
as, type IV pili, Opa and Opc proteins (Dehio, Gray-Owen, & Meyer 2000).
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Fig.1.9. Electron micrograph of Neisserial attachment and invasion of T84 human 
epithelial cells. (Merz & So 2000)
A: Adherence o f Neisseria to the apical plasma membrane in microcolonies. B: Neisseria is 
dispersed and attach as single layer. C: Contact area between Neisseria and host cell 
enlarges. D: Neisseria is internalized.
1.2. Neisseria Lactamica
Much research was focused on the pathogenic species of Neissera due to its disease-causing 
properties and thus naturally less attention has been on the non-pathogenic N.lactamica 
species. But more interest is directed towards these commensal bacteria owing to its 
similarity with N.meningitidis in terms of genomic sequence and key membrane structures.
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At present time, much is still unknown about the host cell interactions with structures on 
N. lactamica but some progress has been made, especially in vaccine development.
Lactamica belongs to the genus Neisseria, which includes meningitidis and gonorrhoeae.
N.lactamica was first described by Hollis et al in 1969 (Hollis, Wiggins, & Weaver 1969). 
Studies before this date were not able to distinguish it from N.meningitidis because acid 
production from lactose was not used as a differential test.
1.2.1. Epidemiology
N. lactamica does not cause disease but is frequently found in the nasopharynx o f humans. 
Carriage is highest in infants and young children but declines with age, which is opposite to 
N.meningitidis where carriage is low in infancy but rises to peak in adolescents and young 
adults (Bennett et al. 2005;Blakebrough et al. 1982).
This converse carriage rate between N. lactamica and N.meningitidis and the fact that 
anti meningococcal bactericidal levels increase in infants with low meningococcal carriage 
is an indirect evidence that N. lactamica may provide protection against N. meningitidis by 
induction o f the immune system (Alber et al. 2001 ;Bennett et al. 2005;Blakebrough et al. 
1982).
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Evidence comes from a study with children in Turkey where the key findings were, 1) 
children under the age o f 2, meningococcal carriage was 5-fold less and N. lactamica 
carriage was higher than that of school children. 2) N.lactamica carriage was significantly 
higher in areas with low incidence of meningococcal disease (Bakir et al. 2001) and also 
from a mathematical model predicting prevalence and incidence, lactamica was found to 
inhibit meningitidis (Coen, Cartwright, & Stuart 2000).
Additionally in a study with experimental mouse models, immunization with N.lactamica 
killed whole cells, outer membrane vesicles and OMPs and protected against isolates of 
serogroup B and C meningococci (Oliver et al. 2002).
1.2.2. Morphology and Structure
Morphology and staining is similar to N.meningitidis, which is a gram-negative diplococci. 
Colony morphology is also similar but generally, colour is more yellowish (Fig. 1.10) 
compared to a much grayish colour of N.meningitidis (Faur, Weisburd, & Wilson 1975).
N tectamica 
2$'h . • 46 fr '. /
V • > »
" z  • d  * i I
*  * * g ' i
\  1 •  *
, * < • , » 4 »
l.-v LA 1 1 i I 1 1 A-. t I (
** 1 c m ' v ,  1 cm
Fig. 1.10. Colony morphology of N.lactamica.
At 24 and 48 hours of growth (www.cdc.gov 2006)
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Both N. lactamica and N. meningitidis colonize the nasopharynx o f humans but differ in 
virulence. Where N.meningitidis can spread into the blood stream causing meningitis and 
sepsis, N.lactamica is commensal, almost never causing disease. Another key difference 
between the two species is that N. lactamica can utilize lactose to produce acid whereas 
N.meningitidis cannot. The differentiation is o f clinical importance and can be marked by 
simple acid production biochemical tests (Alber et al. 2001;www.cdc.gov 2006)
The structure o f N.lactamica is essentially the same as N.meningitidis but without a capsule. 
And many surface antigens are the same to N.meningitidis but without PorA (Sanchez et al. 
2002;Vaughan et al. 2006). Natural immunity to meningococcus is actively induced during 
life and correlates to the amount o f bactericidal activity in humans. This bactericidal 
activity can be induced by non capsular surface antigens in meningicocci but infants are 
rarely colonized by N.meningitidis. Instead, the commensal N.lactamica was found to 
provide natural immunity in children against meningicocci (Gold et al. 1978). It was also 
found that non capsular surface antigens induced bactericidal antibodies, which suggests 
the likelihood that certain surface antigens are shared between N.lactamica and 
N.meningitidis (Kim, Mandrell, & Griffiss 1989). Indeed it has been reported that the 
majority o f N.lactamica strains shared cross-reactive antigens with N.meningitidis (Saez- 
Nieto et al. 1985). Kim et al used sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis and immunoblotting and had identified that it is actually the 
lipooligosaccharides (LOS) on the surface membrane o f N.lactamica that contribute
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towards developing a natural immunity against N.meningitidis. And in this study they 
found that the pathogenic N.meningitidis and N.gonorrheae and non-pathogenic 
N.lactamica share LOS epitopes (Kim, Mandrell, & Griffiss 1989).
1.2.3. Vaccine Development
The fight against N. meningitidis has been especially difficult in terms o f finding a cure to 
disease. In most bacterial infections, a selection o f antibiotics usually kills pathogenic 
organisms but in the case o f N.meningitidis, varying ranges o f antibiotic resistance is 
present. The resistance seen is mostly due to highly variable surface proteins and horizontal 
genetic exchange o f parts o f the chromosomal genes which are resistant. An example is the 
sulfonamide-resistant dihydropterate synthase in N.meningitidis (Maiden 1998).
Horizontal genetic exchange also allows the movement o f these antibiotic resistant alleles 
along different strains o f N.meningitidis, thus increasing the chance o f antibiotic resistance. 
It may also allow movement into different species o f Neissera, like N.lactamica and a 
certain degree o f antibiotic resistance has been reported (Arreaza et al. 2002).
Thus, naturally, development o f a vaccine seems more possible and efficient. A possible 
route towards developing vaccines are the use o f outer membrane vesicles (OMV) o f  
Neisseria meningitidis. OMVs can be collected from the surface blebs o f the membranes in 
both N.meningitidis and N.lactamica and used as a vaccine.
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Previous studies have used OMVs as a potential vaccine against the serogroup B 
meningococcal disease. Efficacy trials have taken place in Cuba, Brazil, and Norway and 
has shown great efficacy in older children and teenagers but not in infants (Gorringe et al. 
2005;Sardinas et al. 2006).
On the other hand, the similarity o f surface structures in N. lactamica and N.meningitidis, 
epidemiological data demonstrating converse carriage rates between N.meningitidis and 
N.lactamica, and results from previous studies confirming the cross reactivity o f antibodies 
against N.lactamica and N.meningitidis, all point towards a vaccine based on N.lactamica 
surface structures. Amongst the many common surface structures, the OMVs have great 
potential and have been shown to provide effective protection against many disease causing 
meningococcal strains (Gorringe et al. 2005;Sardinas et al. 2006).
1.2.4. Genomics
The similarity o f N.lactamica with N.meningitidis is also present in their genomics. It was 
found that the vast majority o f genes present in N. meningitidis was also found in 
N.lactamica. The result being, out o f a total of 1473 probes to genes on pathogenic 
Neisseria, a total o f 1373 probes hybridized to N.lactamica (Synder & Saunders 2006). 
These genes that are shared cannot include virulence genes since N.lactamica is non- 
pathogenic. The genomic regions that are present in N.meningitis but absence from 
N.lactamica are likely to be involved in the pathogenic identity, like invasion ability, o f the
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disease-causing species (Nassif 2002). In detail, to demonstrate the non-existing virulence 
genes on the N.lactamica genome, Synder and Saunders have identified specific virulence 
genes present in N.meningitidis but not N.lactamica. Shown in Fig. 1.11 and Table. 1.1.
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Fig.1.11. The locations of virulence genes present in N.meningitidis but not in 
N.lactamica.
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Panel Chromosomal Region in N.meningitidis N. meningitidis 
virulence gene
N.lactamica gene
A Between murE and murF dca hypothetical
B Between NMB1877 and NMB1884 NMB1880 and 
NMB1882
absent
C Between smpB and NMB1524 virG hypothetical
D Between trpB and coma iga absent
E Between NMB1647 and NMB1645 NMB1646 lacY and lacZ
Table 1.1. Difference in type of genes present at certain locations of the N.meningitidis 
genome.
The complete genome sequencing o f N.lactamica is currently underway at the Sanger 
Institute, with currently a theoretical coverage o f 99.99% o f the genome. This should 
provide valuable information towards a better understanding o f the non-pathogenic 
lactamica (Sanger Institute 2006).
The analysis o f the genome of N.lactamica that have been produced and currently under 
way are o f one particular strain. But N.lactamica exists in many different genotypes and the 
population diversity is poorly understood (Bennett et al. 2005). 17 genotypes were 
identified in 26 N.lactamica strains (Alber et al. 2001) and a even greater number o f 69
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genotypes were found in 75 infants (Bennett et al. 2005). This presents further difficulties 
in choice o f representative isolates for use in vaccine development.
1.2.5. Host Cell Interaction with N.lactamica
N.lactamica is commensal bacteria which shares the same ecological niche, the 
nasopharynx, with the pathogenic N.meningitidis (SaezNito, Marcos, & Vindel 1998). It is 
closely related to both pathogenic Neisseria species, N.meningitidis and N gonorrhoeae but 
rarely has any pathogenic properties (Bennett et al. 2005). In some exceptional 
circumstances, it was found to cause meningitis following skull trauma due to cerebral 
spinal fluid leakage (Denning & Gill 1991), cavitary lung disease following organ 
transplantation (Zavascki et al. 2006), and septicaemia in an adult with cerebral infarcts 
(Brown, Ragge, & Speller 1987).
In most cases, however, N.lactamica does not cause disease, whereas N.meningitidis 
spreads from the nasopharynx to the bloodstream and meninges causing severe meningitis 
and sepsis. Upon host cell contact o f these two different types o f Neisseria, changes in 
certain genes occur. Of the 347 and 285 genes in N. meningitidis and N.lactamica that were 
expressed respectively, only 167 genes were common to both species (Grifantini et al. 
2002). Thus, different subsets of genes seem to be activated by N. meningitidis and 
N.lactamica. This difference may partly explain why one is pathogenic and the other is not.
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Also it was found that 40% of the expressed genes encoded surface-associated proteins 
which suggests both Neisseria undergo extensive surface remodeling upon contact with the 
host cell (Grifantini et al. 2002).
1.3. Inhibitors
1.3.1. MG 132 -  Inhibitor of Proteasome
Proteasomes are responsible for the majority o f protein degradation within the cell 
(Zimmermann et al. 2001). The specific pathway that is involved in this process is the 
ubiquitin proteasome pathway. MG132 is a specific inhibitor o f proteasome which readily 
enter cells (Cowan & Morley 2004). Inhibition o f  this pathway has several results but 
importantly, it can reduce the production o f inflammatory mediators via Nuclear Factor- 
kappaB (NF-kappaB) inhibition (LaFerla-Bruhl et al. 2006;Lee & Goldberg 1998). The 
reduction o f inflammatory mediators may enable N.lactamica or N  meningitidis to 
proliferate or may even reduce disease pathology caused by these mediators and leukocyte 
adhesion molecules in N.meingitidis.
Surfactant proteins on epithelial cells are essential for maintaining normal lung function by 
controlling innate immune responses in the lung (Scanlon et al. 2005). One pathway that is 
important for the maintenance o f  surfactant proteins is the ubiquitin proteasome pathway,
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which is responsible for the degradation o f major intracellular proteins. Proteasome 
inhibition by MG132 results in inhibition o f surfactant protein gene expression which can 
ultimately lead to disease in the lungs due to inability to modulate immune responses (Das 
& Boggaram 2006).
This fact has significant relevance to this project, since the epithelial cells that were used 
were human alveolar epithelial cells and the MG132 treatment would significantly reduce 
the ability o f these cells to modulate the innate immune system. This ‘breakdown’ o f the 
immune responses will possibly have implications towards N.lactamica adhesion and 
invasion. The significant reduction o f adhesion due to MG132 addition could have 
important implications in the role o f the innate immune response towards N.lactamica. 
Since MG132 inhibits the proteasome function, it could be postulated that epithelial 
surfactant proteins are highly responsible for the defense against N. lactamica.
1.3.2. PD98059 -  Inhibitor of MEK
The human cell is subject to many types o f stress during infection by pathogenic or 
sometimes non-pathogenic bacteria. Also, a variety o f cytokines are released as part o f the 
innate immune response. These stimuli activate phosphorylation cascades make use of 
mitogen-activated protein kinases (MAPKs). These MAPKs are also phosphorylated by
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MAPK-activating enzymes (MEKs) and these themselves are activated by phosphorylation 
by MEK kinases (Alessi et al. 1995;Dudley et al. 1995).
PD98059 is a synthetic inhibitor o f this MAP kinase pathway. It is a potent non­
competitive inhibitor which readily passes through the cell membrane (Bioscource 
2006;Pang et al. 1995). In terms o f therapeutic potential, it has been highly regarded as a 
anti-inflammatory agent since it inhibits the synthesis o f interleukin-1 (IL-1) and tumour 
necrosis factor in monocytes induced by bacterial endotoxins (Alessi et al. 1995). Also, 
PD98059 has been implicated in suppression o f T-cell responses which results from the 
inhibition o f interleukin-2 (IL-2) production. Other cytokines associated with T-cell 
responsiveness were also inhibited such as, tumour necrosis factor-alpha (TNF-a), 
interleukin-3 (IL-3), and interferon-gamma (INF-y) (Dumont et al. 1998).
Therefore, it is clear from the evidence that PD98059 can act as an anti-inflammatory agent 
and when cells which have received this inhibitor treatment, there would be a much lesser 
degree of immune action by the cells. In this project, PD98059 was used to treat the A549 
epithelial cells prior to infection o f N.lactamica. This should have definite increased effects 
o f N.lactamica to colonize these cells.
40
1.4. Aims
Despite the similarities in ecological niche, surface protein structure and genomics between 
N. meningitidis and, N.lactamica, the former causes an extensive range o f disease and the 
latter does not. Therefore it will be o f interest to investigate die interactions in terms o f  
adhesion and invasion at the cellular level. The 3 main issues o f  concern following 
infection o f A549 epithelial cells with N.lactamica are:
1) Deduce adhesion patterns o f N. lactamica by Gentamycin Assay
2) Deduce adhesion patterns o f N.lactamica by Fluorescent microscopy
3) Deduce adhesion patterns o f N.lactamica to epithelial cells that have been subject to
MG132 and PD98059 inhibitor treatment.
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CHAPTER II
MATERIAL AND METHODS
IL1. Epithelial Cell Culture
II.l.l. Epithelial Cell Line
A549 epithelial cells are human alveolar basal epithelial cells. A549 cells fall under the 
squamous subdivision o f epithelial cells and are normally used in vitro as model for a type 
II pulmonaiy epithelial cells. In this project, they were used to resemble the epithelial cell 
lining o f the nasopharynx (abeam 2006;Lieber et al. 1976), the niche for both N.lactamica 
and N.meningitidis. The cell line was given by Shaoren Wang, Immunology and Infectious 
Diseases Unit, Institute o f Child Health, UCL.
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II.l .2. Cell Culture Medium
Dulbecco’s modified eagle medium (D-MEM) stored at 4°C.
Containing : 4500mg/l glucose
110mg/l sodium pyruvate
Supplements:
10% Heat inactivated fetal calf serum 
1% 100X L-glutamine (200mM)
1% 100X antibiotic solution
(10,000 U/ml penicillin + 10,000 ug/ml streptomycin)
11.13. Thawing and Seeding
1. Frozen cells were removed from -80°C freezer and were subjected to rapid thawing 
in 37°C water bath.
2. Cells were resuspended in 10ml medium and centrifuged at lOOOg for 5 mins.
3. Pellet was recovered and supernatant discarded.
4. Pellet resuspend in 5 ml medium.
5. Transfered to T-75 (75cm3) flask filled with 5ml medium.
6. They cells were incubated in 37°C humidified incubator with 5% C02.
7. View under inverted microscope for seeding after 24 hours o f incubation.
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11.1.4. Feeding
Cells in culture must be ‘fed’ with appropriate medium containing essential nutrients that 
the cell needs for growth and survival. Also cells produce waste and cell debris thus 
medium must be changed eveiy 2/3 days for optimal growth. Feeding or medium change 
was carried out as follows:
1. Old medium was removed from T-75 flask with pipette.
2. 10 ml sterile PBS (Phosphate Buffered Saline) was added to wash cells.
3. PBS was removed.
4. 10ml fresh medium was added.
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II.1.5. Passaging
When cells reach 70-80% confluence, cells can no longer undergo division and grow due to 
lack o f space on the flask. Thus they need to be passaged or replated onto new flasks.
1. Old medium was removed.
2. 10 ml sterile PBS was added to wash cells.
3. PBS was removed.
4. 5ml tiypsin-EDTA was added to detach cells from flask wall for 3 mins at 37°C.
5. Wall o f the flask was gently tapped to dislodge any remaining cells.
6. Trypsin-EDTA was neutralised with 5ml medium to prevent damage on cells.
7. Re-suspended cells in medium were transferred to conical tube and centrifuged at 
1 OOOg for 5 mins.
8. Supernatant removed and re-suspend pellet in 5ml medium.
9. Re-suspended cells were split into four T-75 flasks with 10ml medium for its use 
within 2 days and split into six T-75 flasks with 10ml medium for use after 3 days.
10. Passaged cells were incubated at 37°C with 5% C02.
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11.1.6. Cell Counting
The number o f cells need to be determined in order to effectively replate them onto new 
flasks or plates.
A cell population o f 1x10% cells and 2x10A5 cells per well were required to re-plate onto 
the 6-well and 24-well plate respectively.
The procedure was as follows:
1. 0.5ml o f re-suspended cell solution was transferred into 1ml eppendorf.
2. Trypan blue mixture is made. Different dilutions were used depending on cell
quantity.
1:2 dilution 1:5 dilution
Trypan blue 20pl 25pl
PBS 20(j.l 25 pi
Cell Solution 20(jJ lOpl
3. 16pl in total o f the mixture was taken and injected into the Haemocytometer.
4. Viewed Haemocytometer under microscope to count cells.
5. Number o f cells in each large square(Fig.2.1) was counted.
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Fig.2.1. Microscopic view of the Haemocytometer.
Number o f cells are counted in each quadrant (a, b, c, d, e , f  g, and h).
The total number o f cells in the suspension solution can be calculated like below: 
(Total haemocytometer cell count / 8 ) X dilution factor X 10A4
Thus, volume o f the cell solution required to plate lx l cells per well 
= 1x10^ / Total number of cells in suspension
47
II.2. N.lactamica Culture
II.2.1. Growth Environment
N.lactamica selectively grows on Gonococcal (GC) agar with additional nutrients. 
N.lactamica was taken from microbeads in horse blood and glycerol that were stored at - 
80°C and spread onto GC agar plates.
GC agar plates with N.lactamica were grown in a humidified incubator at 37°C with 5% 
C02.
GC agar was made up as follows:
1. 37g o f powdered GC agar was mixed with 1L o f DEPC water in a shaker until 
completely dissolved.
2. The mixture was autoclaved.
3. Mixture was left to cool in 50°C water bath.
4. 1% Vitox* supplement was added.
5. 20-25ml o f agar was poured into Petri-dishes.
*'Vitox: a mixture o f nutrients and minerals required for N.lactamica growth. Details shown 
in Appendix I.
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11.2.2. Subculture
N.lactamica was subcultured every 24 hours.
1. 3-5 random colonies were selected and picked with sterile loop.
2. Spread onto warmed GC agar plates like shown in Fig.2.2.
3
Fig.2.2. N.lactamica spreading technique.
1) Spread half the plate back and forth many times to form the ‘lawn’ area. 
N.lactamica will be harvested from this area later for experimentations.
2) and 3) Spread in a single zig-zag line without going back into the lawn area. This is 
to dilute down die quantity of bacteria.
4) Spread in a single line to enable picking of single colonies for subculturing.
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11.2.3. Quantification
Quantification of bacteria is extremely important for adhesion/invasion assays. The number 
o f N.lactamica that are added to the A549 cells must be known in order determine the 
adhesion or invasion rate of N.lactamica. The number of A549 cells can be easily counted 
with the haemocytometer as shown in II. 1.6 ., but determining the numbers of bugs in 
solution cannot be done this way.
In order to quantify N.lactamica in solution, a spectrophotometer must be used to measure 
turbidity o f the bacterial suspension. The spectrophotometer measures the optical density 
(OD) of a particular solution at a certain wavelength. The aim will be to obtain near 
constant colony forming units o f N.lactamica in solution that gives a OD reading of about
1.00 at 540/600 nm wavelength.
D IL U T IO N S
1 0 0 p l 1 0 0 |jl 1 0 0 p l 10OpI 1 OOjjI 100p l
Fig.23. Serial dilutions (A) and 20pl drops of dilution solution for counting (B).
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The quantification method is as follows:
1. NJactmica was harvested from plates grown for at least 12 hours from the law n ' 
area with a sterile cotton bud.
2. This is suspended in 1.2ml of 3 different types of medium. (RMPI* with 10% PCS, 
RPMI without 10% PCS, and Mueller Hinton** medium)
3. Spectrophotometer was calibrated to zero with 900pl of medium without 
N.lactamica.
4. O D  was measured from 90f>nl o f  i n  -1 diluted N.lactamica solution at 540nm and
6G0nm.
5. More medium was added to original stock N.lactamica solution for it to reach a OD 
reading o f 1.00
6. Step 5. was repeated 2-3 times in order to obtain a reading near 1,00
7. Serial dilutions of the stock solution was carried out (Fig 3 ' M
8. 3 x 20pl of each dilution was dropped onto each section of warmed and dry G€ agar 
plates (Fig.2.3.B).
9. GC plates were incubated for 24 hours at 37°C with 5% C02 before counting 
number of colonies.
10. The number of colonies were counted, average calculated, divided by 20pi, and 
times by the dilution factor (e.g. if diluted 1GA~5, dilution factor will be 10A5).
*RPM1 (Roswell Park Memorial Institute) medium contains:
2,000 mg/L D-glucose, non-essential amino acids (NEAA), 110 mg/L sodium pyruvate
** Mueller-Hinton (MH) medium contains:
Meat infusion 2.0g/l, casein hydrolysate 17.5g/1, starch l,5g/l
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11.3. Gentamycin Protection Assay
The Gentamycin protection assay is a very useful tool to study adhesion and invasion 
patterns of bacteria. Gentamycin is an aminoglycoside antibiotic which is used to treat 
many bacterial infections especially Gram-negative bacteria. It works by binding to 
bacterial ribosomes rendering them incapable of reading its genetic code correctly 
[en.wikipedia.org],
Gentamycin was used in this project to evaluate adhesion/invasion properties of 
N.lactamica through the use of the gentamycin protection assay. A schematic diagram is 
shown in Fig.2.4. to explain how this assay works.
*  N.lactamica
*
4.
Inoculation A 5 4 9
Adhesion and 
Invasion of 
N.lactamica
I
G e n t a m y c i n
Gentamycin 
Kills any 
N.Lactamica 
not internalised
Cell lysis 
by Suponin
Fig.2.4. The steps in the Gentamycin Protection Assay
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Introduction of N.lactamica to A549 cells may result in some adhering to the outer 
membrane o f the cell and some invading into the cell cytoplasm. The addition of 
gentamycin kills all lactamica in the surrounding medium and those that have adhered to 
the outer membrane. Only those that have internalized survive. Following this step,
Suponin is added to lyse the epithelial cell, exposing internalized lactamica. This solution 
is spread on a GC agar plate and incubated for 24 hours for colony counting in order to 
determine the number of colony forming units that have invaded.
It is also important to consider possible variables for the gentamycin protection assay. The 
variables that were set for optimal adhesion and invasion were, 4 hours o f infection 
incubation and 1ml of 50pg/ml gentamycin used.
The procedure was as follows:
1. A549 cells were seeded onto two 6-well plate at a number o f 1 x l0 A6 cells per well 
and incubated for 24 hours.
2. A549 cells were inoculated with N.lactamica at a Multiplicity o f Infection (MOI) of 
100 bacteria/cell. This requires lx l 0A8 lactamica per well.
[Note: results from previous quantification experiments indicated that an OD reading of
1.00 corresponds to -5.75x10A8 cfu/ml o f lactamica.
Thus, lxlOA8 / 5.75xl0A8 = 0.17ml o f lactamica solution into each w ell]
3. Incubate for 4 hours at 37°C with 5% C02.
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4. 2 wells were designated for ‘control’ cells without inoculation and 3 wells each 
were designated for ‘adhesion’ and ‘invasion’ assays with inoculation.
5. Adhesion:
a) Remove medium.
b) Wash x3 with PBS.
c) Add 1ml of medium without gentamycin.
d) Incubate for 1 hour at 37°C, 5% C02.
e) Remove medium.
f) Wash x3 with PBS.
g) Add 1ml of 0.5% suponin and incubate for 30 mins at 37°C for cell lysis.
h) Scrape off cells using a cell scraper.
i) Transfer solution into eppendorf. 
j) Vortex vigorously for 30 secs.
k) Dilute stock down to 10A-1 and spread 100 pi o f stock and dilution solution 
onto 1 GC agar plate.
1) Incubate GC agar plates at 37°C, 5% C02 for 24 hours before colony 
counting.
6. Invasion: Same procedure as ‘5. Adhesion’ was taken except for step c) where 1ml 
of 50pg/ml of gentamycin was added to kill any lactamica adhered or in solution.
7. Control cells: Same procedure as ‘5. Adhesion’ was taken.
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II.4. Infection Experiments
II.4.1. Infections 1 to 4.
Prior to the infection experiements, A549 cells were grown on glass coverslips in 24 well 
plates with fibronectin treatment to allow better sticking o f cells to the coverslip. Cells were 
seeded at 2 x 10A5 cells per well.
Infection experiements no’s 1 to 4 were carried out the same way as described below.
1. N.lactamica was harvested from GC plates with sterile cotton swab and suspended 
in RMPI medium with 10% FCS.
2. Turbidity o f suspension solution was adjusted to OD o f  1.00 and bacterial 
suspension was subject to quantification.
3. 250pi o f lactamica solution was mixed with equal volume o f FITC and incubated at 
37°C for 10 mins.
4. FITC stained lactamica was washed and spun down at least 3 times.
5. 34.8pl of this solution was added to each well (OD 1.00 corresponds to -5.75 x 
10A8 CFU/ml and die number o f bacteria required was 2 x 10A7 CFU/ml per 2 x 
10A5 cells. Thus, 34.8pl of bacterial solution was required in each well to make up 
anM O Iof 100).
6. The experiment was stopped at 2, 4, and 6 hours post-infection. The 24 well plate 
used is shown in Fig.2.5.
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Fig.2.5. 24vvcll plate used for infections 1 to 4
It indicates content of each well and for how long the infection took place.
C : Control and B : Bacteria.
In addition, the supernatant for Infection 3 and 4 was quantified to determine the number of 
lactamica present.
The quantification method was the same as in II.2.3.
11.4.2. Infection with Inhibitor Treatment
Prior to the infection experiements, A549 cells were grown on glass coverslips in 24 well 
plates with fibronectin treatment to allow better sticking of cells to the coverslip. Cells were 
seeded at 2 x 10A5 cells per well.
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The infection method was the same as in II.4.1. except that the cells were subject to 
inhibitor (MG132 and PD98059) treatment 1 hour prior to infections. 1 pi of stock MG132 
was added with 840pl DMEM medium and 2 pi of stock PD98059 was added with 541 pi 
DMEM medium. The 24 well plate used is shown in Fig.2.6.
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Fig.2.6. 24well plate used for infection with inhibitor treatment.
It indicates content of each well and for how long the infection took place.
Cl: Control without Infection (no lactamica), C2: Control with Infection {lactamica added), 
MG: MG132, and PD: PD98059
In addition, the supernatant for infection with inhibitor treatment was quantified to 
determine the number of lactamica present.
The quantification method was the same as in n.2.3.
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II.5. Staining
3 types o f stains were used.
Rhodamine/Phalloidin (Rho/Phal) stain
The phalloidin binds specifically to F-actin and does therefore stain the actin stress fibers in 
the cell. Microfilaments stained appear red.
4'-6-Diamidino-2-phenylindole (DAPI) is known to form fluorescent complexes with 
natural double-stranded DNA. It is useful since it passes through the cell membrane and 
marks the position o f the nucleus within a cell. Nucleus stained appear blue.
FITC Fluorescein Isothiocyanate 
N.lactamica stained appear green.
After the infection had been stopped at certain times set (2, 4, or 6 hours), coverslips 
containing A549 cells and FITC stained lactamica was washed 3 times in PBS.
The stages below were followed accordingly.
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1. Wash coverslips 3 times with PBS.
2. Fix with 150pl o f 4% Paraformaldehyde (PFA) and leave for 10 mins at room 
temperature.
3. Wash 3 times with PBS.
4. Permeabilse with 400pl o f 0.5% Triton X100 in PBS and leave for 5 mins at room 
temperature.
5. Wash 3 times with PBS.
6. Block with 400 pi o f 1% BSA and leave at 37°C for 30 mins.
7. 150 pi o f 1:100 Rhodamine/Phalloidin in 1 %  BSA was added and incubated in the 
dark for 30 mins at room temperature.
8. Wash 3 times with PBS.
9. 150 pi o f 1:1000 DAPI in PBS was added and left for 5 mins at room temperature.
10. Coverslips were mounted onto glass slides using Vectorshield.
11. Coverslips were sealed onto glass slides with clear nail vamish.
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11.6. Fluorescent Microscopy
All images were viewed and taken at X63 magnification with oil immersion under a 
standard fluorescent microscope. DAPI, FITC, and Rho/Phal filters were used to view 
fluorescence stained A549 cells and N.lactamica.
Images taken under each filter were merged. Example shown in Fig.2.7.
Fig.2.7. Merging of microscopic images.
Top 3 images show the merging of Rho/Phal and FITC images and the bottom 3 images 
show DAPI and Rho/Phal image merging. DAPI: blue, Rho/Phal: red, and FITC: green.
The number o f N.lactamica was counted in 4 random fields. For those fields that had too 
much lactamica and thus was impossible to count, number was noted as 100.
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CHAPTER III
RESULTS
III.l. Quantifications
The aim of the quantification experiments were first to establish whether there were any 
differences in quantity of lactamica colony forming units (CFU) depending on what type of 
medium was used. The second objective was to obtain a CFU/ml value for N.lactamica that 
corresponds to a spectrophotometer OD reading o f 1.00 which will be used as a reference 
point for gentamycin and infection experiments.
As shown by Fig.3.1, There was no significant difference in CFU/ml value obtained 
between RPMI and Mueller Hinton (MH) medium.
RPMI vs Mueller Hinton (MH)
RPMI
1 2 
expt no.
Fig.3.1. RPMI vs Mueller Hinton medium, CFU/ml values
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Also, more bacteria clumping was observed when using RPMI without 10% Fetal Calf 
Serum (FCS).
Therefore, the medium used was RMPI with 10% FCS for suspending N.lactamica 
harvested from incubated GC plates.
The quantification results are shown in Fig.3.2 with each individual values marked. The 
results are not significantly different and the average value of these results were used for 
future experiements.
Thus, an OD reading of 1.00 of a lactamica suspension solution corresponded to 
5.75 x 10 A8 CFU/ml
Quantifications
1 2 3 4 5 6 7 8 9 10 11 12 13
expt no.
Fig.3.2. Quantifications Results
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III.2. Gentamycin Protection Assay
The gentamycin assay is a useful tool to discriminate between adhered and invaded 
lactamica and also enables viable lactamica to be quantified, since the supernatant is spread 
onto GC agar to count the number of colonies after 24 hours o f growth. The results are 
shown in Table.3.2.
CFU/ml % Adherence / Invasion
Control 200 -
Adhesion 1 390 3.9 x 10A-4 %
Adhesion 2 20 2.0 x 10A-5 %
Invasion 1 0 0
Invasion 2 0 0
Table.3.1. Gentamycin Protection Assay Results
The control, where no lactamica was added surprisingly resulted in 200 CFU/ml being 
present. This probably is due to errors during pipetting where non-frequent changing of 
pipette tips resulted in some lactamica being added to the control well. The percentage of 
adherence was calculated by dividing the CFU by the starting number o f lactamica added, 
which was lx l 0A8 CFU/ml. There was no invasion of the cells by lactamica which was 
expected due to its non-pathogenic nature.
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In conclusion, the gentamycin protection assay is a very sensitive and difficult assay to 
perfect and thus needs much technical experience as well as multiple runs of experiments to 
exactly determine viable counts.
III.3. Infections
A549 epithelial cell infection with N.lactamica was carried out 4 times in total with an 
additional infection experiment with inhibitor treatment. The 4 infection experiements were 
carried out for a total o f 6 hours and experiements stopped at 2 ,4 , and 6 hours post­
infection. The results o f each experiment carry a common theme in terms of N.lactamica 
adhesion patterns but differ in number which may be due to experimental errors rather than 
actual differing adhesion kinetics.
It is difficult to identify by standard fluorescent microscopy on whether lactamica has 
actually invaded the cells. Thus, based on previous Gentamycin assay, where no 
internalized or invading lactamica was found, all lactamica found in fluorescent 
microscopy are considered adhered.
First, Fig.3.3. shows a light microscope image of the A549 epithelial cell without infection 
with N.lactamica. This is to demonstrate what the cells look like before infection with
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N.lactamica. At x40 magnification, the cells can be seen as confluent and densely packed 
with close proximity between each cell. Although it is difficult to see the boarders of the 
cells, at x63 magnification, the individual nuclei (in black circle) and chromatin (red 
circles) can be seen.
x63x40
Fig.3.3. A549 epithelial cells shown by light microscopy at x40 and x63 magnification.
Black circles show the nucleus o f the cells and red circles show the dark chromatin.
III.3.1. Infection 1
The number of N.lactamica that was added to the A549 cells were determined by 
quantification method described in section II.2.3.
At 10A-6 dilution, average number of colony forming units were 8.67 CFU in 20pl.
Thus, quantity added was 4.33x10A8 CFU/ml.
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III. 3.1.1. Adhesion Patterns
Control cells were not infected with N.lactamica thus did not show any FITC stained 
bacteria at 2, 4, and 6 hours (Fig.3.4.A and B).
2 hours post infection resulted in two differing patterns o f colonization by N.lactamica. 
Fig.3.4.C shows extensive colonization by N.lactamica where as in Fig. 3.4.D, there are 
only a few lactamica present, indicated by circles.
Although, it is not possible to verify whether lactamica has internalized or adhered, their 
relative positions within the 3D cellular structure can be distinguished. As shown in 
Fig.3.4.E, F, and G, 4 hours post-infection, different lactamica is seen at different positions. 
These images were taken from the same field but at different focuses. Focus increases as 
we move from E to G, moving from the base towards the outer membranes o f the cell. This 
is true since the coverslips are upside-down and focus is moving from the base to the outer 
structures. Another interesting finding is that at the base o f the cell, lactamica was found to 
adhere in-between the cells (Fig.3.4.E) whereas towards the top surface o f the cell, 
lactamica is seen to adhere possible to the sides and top o f the cells (Fig.3.4.F and G) 
without any discrimination towards adhering site o f cells. Fig.3.4.H. is also an image from 
4 hours post-infection where just a few cells are present.
At 6 hours-post infection, extensive colonization by lactamica can be seen from Fig.3.4.I. 
Colonisation is not random but appears to occur in clusters or groups around the cell.
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III. 3.1.2. Adhesion Numbers
The result from the N.lactamica count per 1000 cells reflects microscopic images above. As 
seen by Fig.3.5. A, the number o f lactamica per 1000 cells differ significantly between the 
2 wells(Bl and B2) at 2 hours and 6 hours post-infection.
III. 3.1.3. Conclusion
The differing number of lactamica present after 2 hours o f infection between the two wells 
may due to human error when adding the bacteria into the wells. This is again reflected at 6 
hours post infection where in the second well, lactamica could not be detected. In terms o f  
numbers o f lactamica that have adhered, Fig.3.5. again represents the abnormal number of 
lactamica at 2 hours post-infection. There could have been a lower concentration of 
lactamica in the B2 wells o f the infection to start with or they may have been accidentally 
washed away during the PBS washing step.
It seems that from Fig.3.4.F, G, and I, lactamica does not have a preference to adhere to 
certain cells or microscopic cellular structure. Further molecular studies need to be 
conducted to confirm this.
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Fig.3.4. Infection 1. Fluorescent Microscopy of DAPI, Rho/Phai, FITC stained A549 
cells and N.lactamica
A and B (control); C (2 hrs, Bl); D (2 hrs, B2); E, F and G (4 hrs, Bl); H (4 hrs, B2); I 
(6hrs, Bl). DAPI stains cell nucleus blue, Rho/Phal stains cell microfilaments red, and 
FITC stains N.lactamica green. White circles indicate FITC stained N.lactamica,
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Fig.3.5. Infection 1. Number of N.lactamica adhesion per 1000 cells at 2,4, and 6 hours.
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III.3.2. Infection 2
The number oiN.lactamica that was added to the A549 cells were determined by 
quantification method described in section n.2.3.
At 10A-6 dilution, average number of colony forming units were 11.67 CFU in 20pl.
Thus, quantity added was 5.83xlOA8 CFU/ml.
III. 3.2.1. Adhesion Patterns
Control cells with DAPI and Rho/Phal staining does not show any lactamica under 
DAPI/Rho/Phal filter (Fig.3 .6.A) and FITC filter (Fig.3.6.B).
Fig.3 .6.C, D, E, and F, shows individual and clusters of lactamica adhered to the cell 
surface at 2 hours post-infection. As focus increases (i.e. from D to F) moving from the 
base to the apex o f the cell, again lactamica was found at different positions within the 
same visual field (indicated by white circles). Interestingly, lactamica that has adhered at 
the base of the cell are present as single diplococci (Fig.3.6.D) and as the focus moves up 
the cell, numbers seem to increase represented by the larger area o f fluorescence (Fig.3.6.E). 
Eventually, as focus reaches the apex o f the cell, lactamica is found in clusters.
At 4 hours post-infection, the number o f lactamica increases considerably which can be 
seen visually in Fig.3.6.G, H, and I. Again, in most cases, lactamica seem to prefer to 
adhere or colonize in clusters, shown by circles.
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There is an even more colonization at 6 hours post-infection (Fig.3 .6. J and K). The 
numbers are uncountable and the positions are not random but appear in clusters around the 
position o f the nucleus.
I ll 3.2.2. Adhesion Numbers
The numbers o f adhered lactamica are similar between the two wells (Bl and B2) at 2 ,4 , 
and 6 hours post-infection. There is an overall increase in the average number with the 
increase in infection time. A marked increase in numbers from 2 hours to 4 hours and a less 
greater increase from 4 hours to 6 hours can be seen (Fig.3.7.).
III. 3.2.3. Conclusion
The clustering o f lactamica towards the apex of the cell may be due to more space being 
available. Since at the base o f the cell, intercellular connections are present and the spread- 
out nature o f the cells create a tighter area thus making it more difficult for lactamica to 
adhere.
The greater increase in lactamica adhesion from 2 hours to 4 hours than 4 hours to 6 hours 
post-infection suggests that after 4 hours o f infection, lactamica acquires greater ability, via 
various endogenous or exogenous compounds, to adhere to epithelial cells. Also, 4 hours of 
infection may be the optimum time for lactamica to interact with and modify the cellular 
membrane components to facilitate its adherence.
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Fig.3.6 Infection 2. Fluorescent Microscopy of DAPI, Rho/Phal, FITC stained A549 
cells and N.lactamica
A and B (control); C (2hrs, B2); D, E and F (2hrs, Bl); G and H (4hrs, Bl); I (4hrs, B2); 
J (6hrs, Bl); K (6hrs, B2)
DAPI stains cell nucleus blue, Rho/Phal stains cell microfilaments red, and FITC stains 
N.lactamica green. White circles indicate FITC stained N.lactamica.
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Fig.3.7. Infection 2. Number of N.lactamica adhesion per 1000 cells at 2,4, and 6 hours.
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111.3.3. Infection 3
The number of N.lactamica that was added to the A549 cells were determined by 
quantification method described in section n.2.3.
At 10A-6 dilution, average number o f colony forming units were 11.67 CFU in 20pl.
Thus, quantity added was 5.84xlOA8 CFU/ml.
I ll 3.3.1. Adhesion Patterns
The overall adhesion was at a minimal level and fluorescent microscopy only showed few 
lactamica in all o f the wells at 2, 4, and 6 hours post-infection (Fig.3 .8).
III. 3.3.2. Adhesion Numbers
Number o f lactamica count was also very low for all wells, reaching on a average of 60 
lactamica per 1000 cells (Fig.3.9).
The supernatant of the well solution after removing the coverslip for staining was analysed 
to quantify the amount o f lactamica present. All CFU numbers counted were at 10A-5 
dilution and thus were multiplied by a dilution factor o f 10A5. The results are shown in 
Table.3.2.
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Number of CFU B1 B2
2 hours 0.72 x 10A8 0.65 x 10A8
4 hours 1.2 x 10A8 1.0 x 10A8
6 hours 1.9 x 10A8 1.9 x 10A8
Table.3.2. Number of N.lactanuca present in the supernatant of B1 and B2 wells at 2 ,4 , 
and 6 hours post-infection.
The number o f lactamica within the supernatant increases with respect to time. The 
numbers roughly doubles from 2 to 4 hours and from 4 to 6 hours.
III. 3.3.3. Conclusion
The reason for this poor adhesion rate in infection 3 may be because o f several reasons.
First, lactamica may not have been stained properly with F1TC or its fluorescence may 
have faded. This is probably not true since not many lactamica can be seen through the 
DAPI filter either (Fig.3.8.B, C, D, E, F, and G). If there are abundant amounts of  
lactamica, it should be distinguishable through the strong DAPI filter as evident in 
Fig.3.11.H, Fig.3.14.D, and Fig.3.15.D. The second reason may be because lactamica have 
been washed away during the PBS washing stage or poor mounting technique onto the 
microscope slides. The third reason is the less-than-desired amount o f lactamica being put 
in for infections. The abundance of lactamica in the supernatant implies that sufficient 
amount o f lactamica was added to the cells. Thus, together with results from the 
supernatant quantifications, poor adhesion due to washed away lactamica is the most 
reasonable answer.
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Fig.3.8 Infection 3. Fluorescent Microscopy of DAPI, Rho/Phal, FITC stained A549 
cells and N.lactamica
A (control); B (2hrs, Bl); C (2hrs, B2); D (4hrs, Bl); E (4hrs, B2); F (6hrs, Bl); G (6hrs,
B2)
DAPI stains cell nucleus blue, Rho/Phal stains cell microfilaments red, and FITC stains 
N.lactamica green. White circles indicate FITC stained N.lactamica.
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Fig.3.9. Infection 3. Number of N.lactamica adhesion per 1000 cells at 2,4, and 6 hours.
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111.3.4. Infection 4
The number of N.lactamica that was added to the A549 cells were determined by 
quantification method described in section EL2.3.
At 10A-6 dilution, average number o f colony forming units were 6.67 CFU in 20pl.
Thus, quantity added was 3.3x10A8 CFU/ml.
I ll 3.4.1. Adhesion Patterns
Infection at 2 and 4 hours resulted in a few lactamica adhered to the cell surface as shown 
in Fig.3.11 A, B, C, D, E, and F. At 6 hours post-infection however, a massive amount of 
lactamica adhesion is seen (Fig.3.11 G, H, and I). It can be seen in Fig.3.11 G and H that 
FITC stained lactamica can also be identified with the DAPI filter, as well as through the 
FITC filter (Fig.3.11.1).
The enormous number o f lactamica colonizing the cells are spread out in a certain fashion. 
The area circled by a white line in Fig.3 .11 .G and H indicates that lactamica does not 
adhere randomly but adheres around the nucleus. Also, in Fig.3 . 11.1,  lactamica is seen to 
colonize nearly the whole area except the region o f the nucleus, circled by a white line. In 
3D, this area corresponds to areas at the side o f the cell rather than on top of or at the base 
o f cells. Due to the nucleus, the cell is not completely flat but has an apex region and 
lactamica preferentially avoids this area as well as areas at the base o f the cell. A schematic 
figure o f this adhesion arrangement is shown in Fig.3.10.
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FITC stained
Rho/Phal stained 
microfilaments DAPI stained Nucleus
Fig.3.10. Schematic figure of N.lactamica adhered to the sides of the cell.
III. 3.4.2. Adhesion Numbers
As shown by Fig.3.12., there isn’t much adhesion until 4 hours post-infection. But at 6 
hours, there is a sudden great increase in adhesion. This suggests that the optimum time for 
greatest number of adhesion is at 6 hours post-infection
The supernatant of the well solution after removing the coverslip for staining was analysed 
to quantify the amount of lactamica present. All CFU numbers counted were at 10A-5 
dilution and thus were multiplied by a dilution factor of 10A5. The results are shown in
Table.3.3.
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Number o f CFU Bl B2
2 hours 0.23 x 10A8 0.33 x 10A8
4 hours 0.78 x 10A8 0.6 x 10A8
6 hours 1.8 x 10A8 2.7 x 10A8
Table.3.3. Number of N.lactamica present in the supernatant o f B l and B2 wells at 2 ,4 , 
and 6 hours post-infection.
The number of lactamica within the supernatant increases with respect to time. The 
numbers roughly triples from 2 to 4 hours and quadruples from 4 to 6 hours.
III. 3.4.3. Conclusion
First, although it is difficult to see the patterns of adhesion for single or small-scale 
colonization, there seems to be a distinct pattern o f adhesion for large colonizations. They 
seem to be mostly around the sides o f the cells and not on top o f  or at the base o f cells.
Also, from Infection 4 experiment lactamica count data, optimum adhesion happens at 
6hours post-infection. Supernatant analysis also provides evidence that lactamica is 
growing and dividing within the medium during the infection process, thus giving a result 
of tripled and quadrupled numbers from 2 to 4 and 4 to 6 hours post-infection respectively.
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Fig.3.11. Infection 4. Fluorescent Microscopy of DAPI, Rho/Phal, FITC stained A549 
cells and N.lactamica
A, B, and C (2hrs, Bl); D and E (4hrs, Bl); F (4hrs, B2); G and H (6hrs, Bl); I (6hrs, 
B2)
DAPI stains cell nucleus blue, Rho/Phal stains cell microfilaments red, and FITC stains 
N.lactamica green. White circles indicate FITC stained N.lactamica (except in I where it 
represents areas occupied by the nucleus).
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III.3.5. Total
The total number of lactamica adhered at 2, 4, and 6 hours was averaged and plot on a 
graph to demonstrate the general trend in change in adhesion numbers (Fig.3.13). 
Consistent with results from Infection 4, there was a great increase at 6 hours. Indicating 
again that optimal conditions for adhesion are present at 6 hours post-infection.
The number of lactamica added to 2xlOA5 cells averaged to 4.82x10A8 CFU. This is a 
higher number than the planned 2x10A7 CFU based on the original MOI o f 100. This is 
about 20 times more lactamica thus giving us a ‘real’ MOI o f 2000 (2000 lactamica per 
cell). The percentage of lactamica adhered to total lactamica added is shown in Table.3.4.
Time Percentage Adherence
2 hr 0.0498 %
4 hr 0.0558 %
6 hr 0.109%
Table.3.4. Percentage adherence of N.lactamica.
The percentage of adherence rates seen here differ significantly from the percentages from 
the gentamycin protection assay (Table.3.2). The difference may be due to loss o f bacteria 
during the cell scrapping and transfer to eppendorf stage or during the extensive PBS 
washes
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Fig.3.13. Average for Infections 1 ,2 ,3 , and 4. Number of N.lactamica adhesion per 
1000 cells at 2,4, and 6 hours.
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II 1.3.6. Infections with Inhibitor Treatment
Both MG132, aproteasome inhibitor, and PD98059, aMEK inhibitor, dampens down the 
innate immune response in different ways. Thus, a marked difference is expected compared 
to the control infection where no inhibitor was added.
The number o f N.lactamica that was added to the A549 cells were determined by 
quantification method described in section n.2.3.
At 10A-6 dilution, average number of colony forming units were 9 CFU in 20pl.
Thus, quantity added was 1.36 x 10^  CFU/ml.
III. 3.6.1. Adhesion Patterns
FITC stained lactamica could not be seen under the FITC filter at 2 hours and 4 hours 
except for PD2 at 4 hours post-infection (Fig.3.15.E). Instead, lactamica could be viewed 
under the DAPI filter on both occasions and there are clear lactamica like structures seen in 
Fig.3.14 and Fig.3.15 indicated by white circles. Thus, lactamica counting was somewhat 
difficult and two different sets of counting was performed, one under the FITC filter and 
the other under the DAPI filter. These yielded two different results.
The general outcome is that, visually, there are greater adhesion numbers at 4 hours post­
infection compared to 2 hours. This may be due to the anti-inflammatory properties o f the 
inhibitors that were added.
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111.3.6.2. Adhesion Numbers
The results from the FITC filter count (Fig.3.16) are somewhat obscure and a clear pattern 
cannot be observed, except that there was greater adherence o f lactamica in inhibitor 
treated cells compared to the control (infection without inhibitor treatment).
In comparison, the results from the DAPI filter count (Fig.3.17) represents a clear increase 
in adhesion from 2 hours to 4 hours post-infection.
At 2 hours post-infection, MG132 and PD98059 treated cells did not present any difference 
towards adhesion rates of lactamica and adhesion numbers for control, MG132, and 
PD98059 were similar. But when it reaches 4 hours, adhesion o f PD98059 treated cells 
were more prone to adhesion by lactamica. A marked increase in adhesion was also seen 
for Infections without inhibitor treatment but the sharp increase was at 6 hours post­
infection. Thus the PD98059 MEK inhibitor may function to shorten the time need for 
optimal adhesion by lactamica.
The supernatant was also quantified, the results are shown in Table.3.5. All CFU numbers 
counted were at 10A-5 dilution and thus were multiplied by a dilution factor o f 10A5.
Number of CFU MG1 MG2 PD1 PD2
2 hours 0.67 x 10A5 0.67 x 10A5 1.33 x 10A5 0.33 x 10A5
4 hours 2.33 x 10A5 2.33 x 10A5 8.67 x 10A5 9.67 x 10A5
Table 3.5. The number of N.lactamica present in the supernatant of MG1,2 and PD1,2 
for 2 and 4 hours post-infection.
The increase in quantity o f lactamica in the supernatant reflects lactamica growth and 
doubling over the course o f die experiment.
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The smaller number of lactamica compared to previous infection experiements is firstly 
because a lower amount o f lactamica was added to the cells. The quantity o f lactamica 
added in Infection 3 and 4 was 5.84xlOA8 CFU/ml and 3.3xlOA8 CFU/ml respectively. In 
this infection experiment, 1.36 x 10*6 CFU/ml was added.
The greater rate o f increase in number reflects the effect o f the inhibitors on the growth of 
lactamica. Number o f lactamica quadruples for MG132 treated cells and numbers increase 
by more than 8 fold for PD98059 treated cells. This indirectly reflects the greater degree o f  
adhesion o f lactamica to PD98059 treated cells (Fig.3.17). Thus, these inhibitors inhibit the 
immune response elements that the cell normally releases into the extracellular space, 
resulting in a higher growth rate o f the lactamica. Also, the results from the quantification 
also supports the result from the DAPI filter count in that many more lactamica are adhered 
to the cell, resulting in a less amount o f lactamica in the supernatant.
III. 3.6.3. Conclusion
The absence o f FITC stained lactamica from the visual field may indicate that the bacteria 
was not stained with FITC properly. This may be due to a shorter incubation period with 
FITC or the FITC itself being out o f date. Another reason could be that lactamica stained 
with FITC lost its fluorescence over a long period o f time thus being undetectable under 
fluorescent microscope.
The count under die DAPI filter should provide sufficient results o f the degree of 
colonization. The relative positions and morphology o f the structures seen under DAPI, 
highly resembled FITC stained lactamica and the numbers adhered also represented an 
increase in adherence with respect to time, which corresponds to previous experiments.
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Fig.3.14. Infection with MG132 (MG) and PD98059 (PD) inhibitors. 2 hours post 
infection. Fluorescent Microscopy of DAPI, Rho/Phal, FITC stained A549 cells and 
N.lactamica
A (control 1, no lactamica, no inhibitors); B (control 2, with lactamica, no inhibitors); C 
(MG1); D (MG2); E (PD1); F (PD2)
DAPI stains cell nucleus blue, Rho/Phal stains cell microfilaments red, and FITC stains 
N.lactamica green. White circles indicate FITC stained N.lactamica.
Fig.3.15. Infection with MG132 (MG) and PD98059 (PD) inhibitors. 4 hours post 
infection. Fluorescent Microscopy of DAPI, Rho/Phal, FITC stained A549 cells and 
N.lactamica
A (control 2, with lactamica, no inhibitors); B (MG1); C (MG2); D and E (PD2)
DAPI stains cell nucleus blue, Rho/Phal stains cell microfilaments red, and FITC stains 
N.lactamica green. White circles indicate FITC stained N.lactamica.
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1000 cells at 2 and 4 hours. MG: MG132 and PD: PD98059
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CHAPTER IV
DISCUSSION
Nmeningitidis is a well-known pathogenic bacteria and causes a wide range of devastating 
disease. Normally it is not pathogenic and resides in the nasopharynx but at times it can 
become invasive and enter the blood stream and meningies and cause spetsis or meningitis 
(Morley & Pollard 2002).
In comparison, not much is yet known about the commensal N.lactamica. It is non- 
pathogenic and hardly ever causes disease. Both these species have similar outer membrane 
structures (Sanchez et al. 2002;Vaughan et al. 2006) and share majority o f genes (Synder & 
Saunders 2006) but their pathogenicity is opposing. Epidemiological studies have also 
concluded that a converse carriage rate between N.meningitidis and N.lactamica was 
evident, of which N.lactamica may protect against meningococcal infections (Alber et al. 
2001;Bennett et al. 2005).
The pathogenic properties o f N.meingitidis are caused by virulence structures which aid 
adhesion and invasion of the host cell (Kallstrom et al. 1997;Merz & So 2000). The stage 
of adhesion seems to be the first and foremost important step in infection by N. meningitidis. 
Adhesion is essential for survival and colonization and thus is crucial for both 
N.meningitidis and N.lactamica. The aim was to investigate the adhesion numbers of
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N.lactamica with respect to time and whether there was significant numbers that had 
adhered at a certain time point. The gentamycin protection assay and fluorescent 
microscopy was used to validate the results.
Massive adhesion o f N.lactamica in some cases (especially at 6 hours post infection) were 
seen which could be implicated for the survival o f these commensals. Overall there was a 
pattern o f adherence that resembled a sudden increase in adhesion at 6 hours post-infection. 
This could be due to certain morphological changes in surface bound protein or 
configuration o f the host cell membrane for optimum adherence at 6 hours. Further 
experiments for long periods o f time (i.e. 0 to 12 or 0 to 24 hours) will help determine at 
which time is the peak for adhesion rates for lactamica.
Fluorescent microscopy analysis of adhesion patterns of N lactamica revealed that it mostly 
adhered to the sides o f the cells and not the base or towards the apex. This may simply 
reflect the structure of the outer surface o f the cells in that the base o f the cells are more 
tightly bound together leaving few grooves or spaces for lactamica to adhere to. Or, it may 
suggest more complex receptors or proteins available at certain locations across the cellular 
surface. It is known that N.meningitidis infections have a distinct pattern o f adhesion. After 
a few hours of infection, microcolonies o f 10-100 N meningitidis adhere first the apical 
cellular membrane (Merz & So 2000), which differs from N.lactamica adhesion patterns. 
This difference is no conclusive however, due to the fact that the model epithelial cells used
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in this project were alveolar epithelium, which may have different consequences for 
adhesion. Also, the fact that this in vitro model does not have a mucous barrier, it does not 
fully simulate the in vivo adhesion pattern of N.lactamica.
In comparison to adhesion rates o f N. meningitidis from Shaoren Wang (Appendix II), 
where the same MOI and infection environment was used, there was relatively less 
lactamica adhesion than meningitidis adhesion. This may reflect the more effective 
mechanisms or the presence o f certain adhesion aiding structures (typelV pili) in 
meningitidis for efficient adhesion to host cells (Merz & So 2000).
It must be noted that there are clear limitations o f counting by 4 visual fields. Many 
lactamica could be missed and important numbers could not be included in the results.
Thus in future experiments, counts from 6 or more visual fields is desirable.
Analysis o f the supernatant o f the wells after removing coverslips with cells and adhered 
lactamica, revealed an increase in lactamica number in the surrounding supernatant. This 
was surprising since with an increase in adherence to the cell, theoretically there should be 
less numbers o f lactamica in the supernatant. There appears to be active growth of 
lactamica within the DMEM medium required for cell survival. And in fact, the high 
number o f lactamica adherence at 6 hours post-infection, may reflect the additional number 
of increased lactamica due to growth.
But why isn’t there a similar pattern o f adhesion at 4 hours-post infection? Despite the 
doubling or tripling of number o f lactamica in the supernatant from 2 hours to 4 hours post­
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infection, there isn’t a large increase in adhesion numbers. This may be due to differing 
growth and adhesion properties of N.lactamica. Growth or doubling o f lactamica may be 
relatively linear on a timescale of 0 to 6 hours but adhesion rates may peak between 4 and 6 
hours. The exact adhesion dynamics and mechanics o f N.lactamica are not well known but 
it seems that at 6 hours post-infection, optimum configuration o f the A549 cells by 
lactamica enables great adhesion rates.
All in all, there is a need for further experiementation in order to make more clear o f the 
results encountered in this project. Some examples o f further study that need to be carried 
out are as follows.
- Invasion / Adhesion assay on whole tissue cultures, possibly with a mucosal barrier
- Confocal microscopy to distinguish between adhesion and invasion.
- Mastering the gentamycin assay. Since, many trials leads to improvement in technique 
and results.
- Analysis of the supernatant to see whether certain inflammatory mediators or bacterial 
products are present.
The findings from adhesion and invasion studies may provide valuable knowledge on the 
dynamics of N.lactamica colonization compared to those o f N. meningitidis. But this is only 
part o f the large picture in elucidating why N.lactamica does not cause disease and its role 
in protection against N.meningitidis. Advanced molecular biology will hopefully help
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discover previously unidentified receptors or molecules that N.lactamica uniquely posess 
and the completion of the genomic sequence will also provide valuable information on 
certain proteins involved in colonization.
A better understanding o f a possible relationship between immunosuppression, 
nasopharyngeal colonization, and invasive disease may determine the real importance of 
N. Lactamica as an adult human pathogen. Also, an improved understanding of the 
population biology o f N.lactamica will provide valuable insights for investigating the role 
that N.lactamica plays in inducing immunity against the meningococcus and in choosing 
isolates and subcellular components that might be suitable for meningococcal vaccines.
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Appendix II
Adhesion number counts from infections reactions of two strains of N. meningitidis. 
From Shaoren Wang,
Infectious Disease and Microbiology Unit, Institute of Child Health, UCL.
Adhesion and internalisation of H44776 Wild Type by A549 cells
(porin stain)
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Adhesion and Internalisation of H44/76 SiaD by A549 cells (porin
stain)
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